Criteria for designation of clinical substage in canine lymphoma: a survey of veterinary oncologists
Authors:
- 23 February 2014
- journal article
- Published by Wiley in Veterinary and Comparative Oncology
- Vol. 14 (S1) , 32-39
Abstract
Clinical substage is frequently reported to be prognostic in dogs with lymphoma, yet formal criteria for defining this parameter are lacking. The World Health OrganizationTNMClassification of Tumors of Domestic Animals simply defines substage as the absence or presence of systemic signs (substages a and b, respectively). We designed a survey to query veterinary oncologists on the criteria they use to determine clinical substage in practice. Gastrointestinal, constitutional and respiratory signs were the most commonly identified clinical factors, with greater than 90% respondents indicating that inappetence, vomiting, diarrhoea, changes in attitude, weakness and dyspnea were integral in assigning clinical substage. Nevertheless, more than three‐quarters of respondents also considered metabolic, neurologic and nutritional parameters when making this determination. For most factors, respondents reported mild‐to‐moderate severity of clinical signs was sufficient for substage b designation.Keywords
Funding Information
- Tufts Cummings School of Veterinary Medicine
This publication has 19 references indexed in Scilit:
- Clinical characteristics, treatment, and outcome of dogs with presumed primary hepatic lymphoma: 18 cases (1992–2008)Journal of the American Veterinary Medical Association, 2011
- Predictors of long-term survival in dogs with high-grade multicentric lymphomaJournal of the American Veterinary Medical Association, 2011
- CHOP chemotherapy for the treatment of canine multicentric T‐cell lymphomaVeterinary and Comparative Oncology, 2011
- Comparison between l-CHOP and an l-CHOP protocol with interposed treatments of CCNU and MOPP (l-CHOP-CCNU-MOPP) for lymphoma in dogsVeterinary and Comparative Oncology, 2010
- Outcome and toxicity associated with a dose-intensified, maintenance-free CHOP-based chemotherapy protocol in canine lymphoma: 130 casesVeterinary and Comparative Oncology, 2010
- Clinical Outcomes of 30 Cases (1997–2004) of Canine Gastrointestinal LymphomaJournal of the American Animal Hospital Association, 2007
- Treatment of Dogs with Lymphoma Using a 12-Week, Maintenance-Free Combination Chemotherapy ProtocolJournal of Veterinary Internal Medicine, 2006
- Chemotherapy Followed by Half-Body Radiation Therapy for Canine LymphomaJournal of Veterinary Internal Medicine, 2004
- Evaluation of a 6-Month Chemotherapy Protocol with No Maintenance Therapy for Dogs with LymphomaJournal of Veterinary Internal Medicine, 2002
- Evaluation of Prognostic Factors and Sequential Combination Chemotherapy With Doxorubicin for Canine LymphomaJournal of Veterinary Internal Medicine, 1993